Acquisition of Patents Related to Conversation Constraints and Hyaluronic Acid Production Methods
[Asia Economy Reporter Geum Bo-ryeong] Daehwa Pharmaceutical announced on the 1st that it has acquired a patent related to the "expression system for hyaluronic acid production using non-pathogenic bacteria and the method of producing hyaluronic acid using the said expression system."
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- 'Still Hesitant? If You're Wondering Whether KOSPI Will Rise, This Is the Number You Must Watch [Weekend Money]'
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
Daehwa Pharmaceutical explained, "Using hyaluronic acid produced by the non-pathogenic microorganism Bacillus as a raw material, it is possible to develop pharmaceuticals such as cosmetic fillers, adhesion prevention agents, and arthritis treatments."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
